KR19990022137A - 2-(1h-4(5)-이미다조일) 시클로프로필 유도체 - Google Patents
2-(1h-4(5)-이미다조일) 시클로프로필 유도체Info
- Publication number
- KR19990022137A KR19990022137A KR1019970708616A KR19970708616A KR19990022137A KR 19990022137 A KR19990022137 A KR 19990022137A KR 1019970708616 A KR1019970708616 A KR 1019970708616A KR 19970708616 A KR19970708616 A KR 19970708616A KR 19990022137 A KR19990022137 A KR 19990022137A
- Authority
- KR
- South Korea
- Prior art keywords
- imidazoyl
- pharmaceutically acceptable
- compound
- cyclopropanamide
- cyclopropyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C07D233/60—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to ring nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Photoreceptors In Electrophotography (AREA)
- Paints Or Removers (AREA)
- Silver Salt Photography Or Processing Solution Therefor (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8/453,359 | 1995-05-30 | ||
| US08/453,359 US5652258A (en) | 1995-05-30 | 1995-05-30 | 2-(4-imidazoyl) cyclopropyl derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR19990022137A true KR19990022137A (ko) | 1999-03-25 |
Family
ID=23800267
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019970708616A Ceased KR19990022137A (ko) | 1995-05-30 | 1996-05-29 | 2-(1h-4(5)-이미다조일) 시클로프로필 유도체 |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US5652258A (cg-RX-API-DMAC7.html) |
| EP (1) | EP0837679B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2001503013A (cg-RX-API-DMAC7.html) |
| KR (1) | KR19990022137A (cg-RX-API-DMAC7.html) |
| CN (1) | CN1100534C (cg-RX-API-DMAC7.html) |
| AT (1) | ATE207354T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU713767B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2222101A1 (cg-RX-API-DMAC7.html) |
| DE (1) | DE69616328T2 (cg-RX-API-DMAC7.html) |
| DK (1) | DK0837679T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2163019T3 (cg-RX-API-DMAC7.html) |
| FI (1) | FI974363A0 (cg-RX-API-DMAC7.html) |
| MX (1) | MX9709211A (cg-RX-API-DMAC7.html) |
| NO (1) | NO975484D0 (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ308410A (cg-RX-API-DMAC7.html) |
| PT (1) | PT837679E (cg-RX-API-DMAC7.html) |
| WO (1) | WO1996038141A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5652258A (en) * | 1995-05-30 | 1997-07-29 | Gliatech, Inc. | 2-(4-imidazoyl) cyclopropyl derivatives |
| US6008240A (en) * | 1997-12-15 | 1999-12-28 | Gliatech, Inc. | 2-(1H-4(5)-imidazoyl) cyclopropyl derivatives |
| WO2000042023A1 (en) | 1999-01-18 | 2000-07-20 | Novo Nordisk A/S | Substituted imidazoles, their preparation and use |
| US7265115B2 (en) | 1999-01-29 | 2007-09-04 | Abbott Laboratories | Diazabicyclic CNS active agents |
| US6908926B1 (en) | 1999-04-16 | 2005-06-21 | Novo Nordisk A/S | Substituted imidazoles, their preparation and use |
| US6114350A (en) * | 1999-04-19 | 2000-09-05 | Nen Life Science Products, Inc. | Cyanine dyes and synthesis methods thereof |
| US6610721B2 (en) | 2000-03-17 | 2003-08-26 | Novo Nordisk A/S | Imidazo heterocyclic compounds |
| US6437147B1 (en) | 2000-03-17 | 2002-08-20 | Novo Nordisk | Imidazole compounds |
| EP1313470A4 (en) | 2000-08-17 | 2005-02-16 | Gliatech Inc | NEW ALICYCLIC IMIDAZOLE AS H 3 ACTIVE SUBSTANCES |
| EP1320364A1 (en) * | 2000-08-21 | 2003-06-25 | Gliatech, Inc. | The use of histamine h3-receptor inverse agonists for the control of appetite and treatment of obesity |
| WO2002067938A2 (en) * | 2000-10-30 | 2002-09-06 | Schering Corporation | Treating or reducing the risk of cardiovascular disease |
| AU2003248584A1 (en) * | 2002-03-01 | 2003-09-16 | Warner-Lambert Company Llc | Method of treating osteoarthritis |
| EP1720847A1 (en) * | 2004-02-02 | 2006-11-15 | Pfizer Products Incorporated | Histamine-3 receptor modulators |
| US7902191B2 (en) | 2004-02-25 | 2011-03-08 | Eli Lilly And Company | Histamine H3 receptor antagonists, preparation and therapeutic uses |
| CA2561628C (en) | 2004-04-01 | 2012-05-08 | Eli Lilly And Company | Histamine h3 receptor agents, preparation and therapeutic uses |
| CN1956952B (zh) * | 2004-06-02 | 2013-12-11 | 伊莱利利公司 | 组胺h3受体药剂、制备和治疗学用途 |
| EP1784400B1 (en) | 2004-08-23 | 2015-01-14 | Eli Lilly And Company | Histamine h3 receptor agents, preparation and therapeutic uses |
| WO2006044228A1 (en) | 2004-10-18 | 2006-04-27 | Eli Lilly And Company | Histamine h3 receptor inhibitors, preparation and therapeutic uses |
| DE602006010833D1 (de) * | 2005-03-17 | 2010-01-14 | Lilly Co Eli | Pyrrolidinderivate als histamin-h3-rezeptorantagonisten |
| EP1707203A1 (en) | 2005-04-01 | 2006-10-04 | Bioprojet | Treatment of parkinson's disease obstructive sleep apnea, dementia with lewy bodies, vascular dementia with non-imidazole alkylamines histamine H3- receptor ligands |
| CN101151244B (zh) | 2005-04-01 | 2014-09-03 | 伊莱利利公司 | 组胺h3受体活性剂、制备和治疗用途 |
| EP1717233A1 (en) * | 2005-04-29 | 2006-11-02 | Bioprojet | Histamine H3-receptor ligands and their therapeutic application |
| EP1717235A3 (en) | 2005-04-29 | 2007-02-28 | Bioprojet | Phenoxypropylpiperidines and -pyrrolidines and their use as histamine H3-receptor ligands |
| US20100137391A1 (en) * | 2005-09-15 | 2010-06-03 | Ryo Yoshimoto | Histamine H3 Agonist for use as Therapeutic Agent for a Lipid/Glucose Metabolic Disorder |
| EP1942104A1 (en) * | 2006-12-20 | 2008-07-09 | sanofi-aventis | Heteroarylcyclopropanecarboxamides and their use as pharmaceuticals |
| US8993808B2 (en) | 2009-01-21 | 2015-03-31 | Oryzon Genomics, S.A. | Phenylcyclopropylamine derivatives and their medical use |
| WO2011035941A1 (en) | 2009-09-25 | 2011-03-31 | Oryzon Genomics S.A. | Lysine specific demethylase-1 inhibitors and their use |
| US8946296B2 (en) | 2009-10-09 | 2015-02-03 | Oryzon Genomics S.A. | Substituted heteroaryl- and aryl-cyclopropylamine acetamides and their use |
| WO2011106574A2 (en) | 2010-02-24 | 2011-09-01 | Oryzon Genomics, S.A. | Inhibitors for antiviral use |
| WO2011106106A2 (en) | 2010-02-24 | 2011-09-01 | Oryzon Genomics, S.A. | Lysine demethylase inhibitors for diseases and disorders associated with hepadnaviridae |
| RS55348B1 (sr) | 2010-04-19 | 2017-03-31 | Oryzon Gnomics S A | Inhibitori lizin specifične demetilaze-1 i njihova upotreba |
| EP2598480B1 (en) | 2010-07-29 | 2019-04-24 | Oryzon Genomics, S.A. | Cyclopropylamine derivatives useful as lsd1 inhibitors |
| DK2598482T3 (en) | 2010-07-29 | 2018-06-14 | Oryzon Genomics Sa | ARYLCYCLOPROPYLAMINE-BASED DEMETHYLASE INHIBITORS OF LSD1 AND THEIR MEDICAL USE |
| WO2012045883A1 (en) | 2010-10-08 | 2012-04-12 | Oryzon Genomics S.A. | Cyclopropylamine inhibitors of oxidases |
| WO2012072713A2 (en) | 2010-11-30 | 2012-06-07 | Oryzon Genomics, S.A. | Lysine demethylase inhibitors for diseases and disorders associated with flaviviridae |
| EP2712315B1 (en) | 2011-02-08 | 2021-11-24 | Oryzon Genomics, S.A. | Lysine demethylase inhibitors for myeloproliferative disorders |
| US9469597B2 (en) | 2011-10-20 | 2016-10-18 | Oryzon Genomics S.A. | (Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors |
| AU2012324803B9 (en) | 2011-10-20 | 2017-08-24 | Oryzon Genomics, S.A. | (hetero)aryl cyclopropylamine compounds as LSD1 inhibitors |
| WO2013151982A1 (en) | 2012-04-03 | 2013-10-10 | Arena Pharmaceuticals, Inc. | Methods and compounds useful in treating pruritus, and methods for identifying such compounds |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2579596B1 (fr) * | 1985-03-26 | 1987-11-20 | Inst Nat Sante Rech Med | (imidazolyl-4) piperidines, leur preparation et leur application en therapeutique |
| FR2671083B1 (fr) * | 1990-12-31 | 1994-12-23 | Inst Nat Sante Rech Med | Nouvelles 4-(4-imidazolyl) piperidines substituees en 1, leur preparation ainsi que leurs applications therapeutiques. |
| EP0573542B1 (en) * | 1991-02-27 | 1997-10-15 | Seed Capital Investments( Sci) B.V. | Imidazole-derivatives having antagonistic activity on the histamine h3-receptor |
| FR2686084B1 (fr) * | 1992-01-10 | 1995-12-22 | Bioprojet Soc Civ | Nouveaux derives de l'imidazole, leur preparation et leurs applications therapeutiques. |
| US5217986A (en) * | 1992-03-26 | 1993-06-08 | Harbor Branch Oceanographic Institution, Inc. | Anti-allergy agent |
| US5652258A (en) * | 1995-05-30 | 1997-07-29 | Gliatech, Inc. | 2-(4-imidazoyl) cyclopropyl derivatives |
-
1995
- 1995-05-30 US US08/453,359 patent/US5652258A/en not_active Expired - Fee Related
-
1996
- 1996-05-29 DK DK96914788T patent/DK0837679T3/da active
- 1996-05-29 PT PT96914788T patent/PT837679E/pt unknown
- 1996-05-29 EP EP96914788A patent/EP0837679B1/en not_active Expired - Lifetime
- 1996-05-29 WO PCT/US1996/007833 patent/WO1996038141A1/en not_active Ceased
- 1996-05-29 FI FI974363A patent/FI974363A0/fi not_active IP Right Cessation
- 1996-05-29 ES ES96914788T patent/ES2163019T3/es not_active Expired - Lifetime
- 1996-05-29 KR KR1019970708616A patent/KR19990022137A/ko not_active Ceased
- 1996-05-29 US US08/945,915 patent/US5990317A/en not_active Expired - Fee Related
- 1996-05-29 JP JP08536597A patent/JP2001503013A/ja not_active Ceased
- 1996-05-29 CN CN96195925A patent/CN1100534C/zh not_active Expired - Fee Related
- 1996-05-29 DE DE69616328T patent/DE69616328T2/de not_active Expired - Fee Related
- 1996-05-29 NZ NZ308410A patent/NZ308410A/en unknown
- 1996-05-29 AU AU58047/96A patent/AU713767B2/en not_active Ceased
- 1996-05-29 CA CA002222101A patent/CA2222101A1/en not_active Abandoned
- 1996-05-29 AT AT96914788T patent/ATE207354T1/de not_active IP Right Cessation
-
1997
- 1997-11-27 MX MX9709211A patent/MX9709211A/es not_active IP Right Cessation
- 1997-11-28 NO NO975484A patent/NO975484D0/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE69616328D1 (de) | 2001-11-29 |
| FI974363L (fi) | 1997-11-28 |
| DE69616328T2 (de) | 2002-07-04 |
| FI974363A7 (fi) | 1997-11-28 |
| US5990317A (en) | 1999-11-23 |
| MX9709211A (es) | 1998-07-31 |
| EP0837679A4 (en) | 1999-03-03 |
| AU713767B2 (en) | 1999-12-09 |
| DK0837679T3 (da) | 2002-02-11 |
| EP0837679B1 (en) | 2001-10-24 |
| NZ308410A (en) | 2001-06-29 |
| FI974363A0 (fi) | 1997-11-28 |
| EP0837679A1 (en) | 1998-04-29 |
| JP2001503013A (ja) | 2001-03-06 |
| ATE207354T1 (de) | 2001-11-15 |
| WO1996038141A1 (en) | 1996-12-05 |
| CA2222101A1 (en) | 1996-12-05 |
| AU5804796A (en) | 1996-12-18 |
| ES2163019T3 (es) | 2002-01-16 |
| CN1100534C (zh) | 2003-02-05 |
| CN1192143A (zh) | 1998-09-02 |
| NO975484D0 (no) | 1997-11-28 |
| US5652258A (en) | 1997-07-29 |
| PT837679E (pt) | 2002-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0837679B1 (en) | 2-(1h-4(5)-imidazoyl) cyclopropyl derivatives | |
| KR19990022136A (ko) | 1h-4(5)-치환 이미다졸 유도체 | |
| RU2165933C2 (ru) | Производные пиперазина, способ их получения, фармацевтическая композиция и способ лечения синдрома 8-oh-dpat | |
| JP2002509908A (ja) | アミノシクロヘキシルエーテル化合物およびその用途 | |
| KR100341950B1 (ko) | 뇌세포보호제 | |
| IL174942A (en) | Derivatives of n-[phenyl(piperidine-2-yl)methyl]arylamides, pharmaceutical compositions comprising them and their use in the preparation of medicaments | |
| US6448282B1 (en) | 1H-4(5)-substituted imidazole derivatives | |
| EP0841923B1 (en) | 1h-4(5)-substituted imidazole derivatives | |
| EP0499987A1 (en) | Platelet activating factor antagonists | |
| JPH05262723A (ja) | 新規ピロリジン化合物 | |
| FI89799C (fi) | Foerfarande foer framstaellning av terapeutiskt aktiva 2,5-diazabicyklo/2.2.1/heptanderivat | |
| KR20010110806A (ko) | 아미노알킬 치환된 (벤조디옥산, 벤조푸란 또는 벤조피란)유도체 | |
| JP4093431B2 (ja) | 血管収縮性の置換2,3−ジヒドロ−1,4−ジオキシノピリジン | |
| JP2002500658A (ja) | 2−アミノ−7−(1−置換−2−ヒドロキシエチル)−3,5−ジヒドロピロロ[3,2−d]ピリミジン−4−オン | |
| US6072057A (en) | 1H-4(5)-cyclo-substituted imidazole derivatives as histamine H3 receptor agents | |
| CZ8197A3 (en) | (1h-indol-4-yl)-piperidine- or tetrahydropyridine ethyl amines and -ethyl carboxamides and pharmaceutical composition containing thereof | |
| JP2009522246A (ja) | ムスカリン性レセプターアンタゴニスト | |
| RU2114828C1 (ru) | Энантиомеры ароматических азотсодержащих производных и их соли с неорганическими или органическими кислотами и способ их получения | |
| JP3007675B2 (ja) | 新規なインドール誘導体 | |
| KR20020016938A (ko) | 함질소화합물을 유효성분으로 하는 신경장해개선제 | |
| MXPA97009210A (en) | Derivatives of imidazol ih-4 (5) -substitui | |
| NZ314062A (en) | 4-[1-[2-(pyridin-2-ylaminopropyl)]-piperidin-4-yl]indole derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 19971129 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20010313 Comment text: Request for Examination of Application |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20030430 Patent event code: PE09021S01D |
|
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
Patent event date: 20031117 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20030430 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |